Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Computer model aims to Fine-Tune Kids' transplant meds

NCT ID NCT06095895

Summary

This study tested a computer-based method to personalize the doses of two key anti-rejection medications (tacrolimus and mycophenolic acid) for children who have received a kidney transplant. The goal was to see if using a model to predict drug levels in the blood could help doctors adjust doses more precisely for each child. Researchers followed 29 young patients to check if the model's predictions matched their actual future drug levels, aiming to improve long-term medication management.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Radboudumc

    Nijmegen, Gelderland, 6500HB, Netherlands

Conditions

Explore the condition pages connected to this study.